RNS Number : 1977L
Aferian PLC
04 September 2023
 

4 September 2023

 

Aferian plc

Directors' Dealings

Aferian plc (LSE:AFRN, "Company" or "AFRN") received notification on the 01 September 2023 from Kestrel Partners LLP ("Kestrel") that on the 01 September 2023 it purchased, on behalf of its discretionary client accounts, an aggregate of 100,000 ordinary shares of 1p each each ("Shares") in the Company at an average price of 12.5 pence per share.

Mr Royde is a partner of, and holds a beneficial interest in, Kestrel. Mr Royde is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in AFRN.

Following this transaction, Kestrel Opportunities holds (and consequently Mr Royde is deemed to have a beneficial interest in) 16,784,114 Shares in the Company, and other clients of Kestrel, in which Mr Royde has no beneficial interest hold 11,942,622 Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 28,726,736 Shares in the Company, which represents 25.83 per cent of the total voting rights in the Company.

Kestrel's interest in the Shares in the Company is held through the following nominees:

Holding type

Nominee

No. of shares

% of total voting rights

Indirect

Bank of New York Nominees Ltd

16,784,114

                               15.09%

Indirect

JIM Nominees Limited

631,163

0.57%

Indirect

Bank of New York Nominees Ltd

7,463,390

6.71%

Indirect

Northern Trust Company AVFC

3,848,069

3.46%

 

For further information contact:

 


Aferian Plc

Donald McGarva, Chief Executive Officer

Mark Carlisle, Chief Financial Officer

 +44 (0) 1223 598197

 


 

Investec (NOMAD and Broker)

David Anderson / Patrick Robb / Nick Prowting / Cameron MacRitchie

 

+44 (0) 20 7597 5970

 

FTI Consulting LLP (Financial Communications)

Matt Dixon / Emma Hall / Tom Blundell / Aisha Hamilton

+44 (0) 203 3727 1000

 

 





 

ANNEX

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kestrel Partners LLP

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA - Max Royde (non-executive director Aferian plc)

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Aferian plc

b)

 

LEI

 

21380068JIMBNNZJL315

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of 1p each 

 

ISIN: GB00B013SN63

 

b)

 

Nature of the transaction

 

 Purchase

c)

 

Price(s) and volume(s)

 

Transfer

 

Purchase

 

Purchase

01 September 2023

Price(s)

 

Volume(s)

12.5 pence

100,000 shares


d)

 

Aggregated information

- Aggregated volume

- Price

 

Purchase Total 100,000 shares at an average price of 12.5 pence.

e)

 

Date of the transaction

 

01 September 2023

f)

 

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZZGGLFFFGFZM